Human vaccination against RH5 induces neutralizing antimalarial antibodies that inhibit RH5 invasion complex interactions.

JCI Insight
Ruth O PayneSimon J Draper

Abstract

The development of a highly effective vaccine remains a key strategic goal to aid the control and eventual eradication of Plasmodium falciparum malaria. In recent years, the reticulocyte-binding protein homolog 5 (RH5) has emerged as the most promising blood-stage P. falciparum candidate antigen to date, capable of conferring protection against stringent challenge in Aotus monkeys. We report on the first clinical trial to our knowledge to assess the RH5 antigen - a dose-escalation phase Ia study in 24 healthy, malaria-naive adult volunteers. We utilized established viral vectors, the replication-deficient chimpanzee adenovirus serotype 63 (ChAd63), and the attenuated orthopoxvirus modified vaccinia virus Ankara (MVA), encoding RH5 from the 3D7 clone of P. falciparum. Vaccines were administered i.m. in a heterologous prime-boost regimen using an 8-week interval and were well tolerated. Vaccine-induced anti-RH5 serum antibodies exhibited cross-strain functional growth inhibition activity (GIA) in vitro, targeted linear and conformational epitopes within RH5, and inhibited key interactions within the RH5 invasion complex. This is the first time to our knowledge that substantial RH5-specific responses have been induced by immunizat...Continue Reading

References

Jan 1, 1987·Parasite Immunology·A Saul
Feb 26, 2008·Genome Research·K Mark BushellGavin J Wright
Jun 20, 2008·Nature Immunology·Jean LanghorneKevin Marsh
Jul 29, 2008·Nature Medicine·Simon J DraperAdrian V S Hill
Feb 19, 2010·Science Translational Medicine·Shannon L TakalaChristopher V Plowe
Nov 26, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·Simon J DraperAdrian V S Hill
Aug 25, 2011·Molecular Therapy : the Journal of the American Society of Gene Therapy·Susanne H SheehySimon J Draper
Jan 6, 2012·Science Translational Medicine·Eleanor BarnesPaul Klenerman
Jan 26, 2012·The Journal of Infectious Diseases·Geraldine A O'HaraAdrian V S Hill
Oct 24, 2012·Molecular Therapy : the Journal of the American Society of Gene Therapy·Susanne H SheehySimon J Draper
Jan 12, 2013·Molecular and Biochemical Parasitology·Karen HaytonThomas E Wellems
Apr 20, 2013·Proceedings of the National Academy of Sciences of the United States of America·Else M BijkerRobert W Sauerwein
Jun 19, 2013·The Journal of Immunology : Official Journal of the American Association of Immunologists·Jack S RichardsJames G Beeson
Oct 30, 2013·Molecular Therapy : the Journal of the American Society of Gene Therapy·Nicola BorthwickTomáš Hanke
Nov 19, 2013·Lancet·Vasee S MoorthyJean-Marie Okwo-Bele
Dec 3, 2013·The Journal of Immunology : Official Journal of the American Association of Immunologists·Alexander D DouglasSimon J Draper
Dec 4, 2013·Proceedings of the National Academy of Sciences of the United States of America·Madushi WanaguruGavin J Wright
Mar 22, 2014·PLoS Pathogens·Gavin J Wright, Julian C Rayner
Jun 17, 2014·Molecular Therapy : the Journal of the American Society of Gene Therapy·Domtila KimaniKatie J Ewer
Aug 1, 2014·Science Translational Medicine·Faith H OsierKevin Marsh
Aug 27, 2014·Molecular Therapy : the Journal of the American Society of Gene Therapy·Susanne H HodgsonSimon J Draper
Jan 15, 2015·Proceedings of the National Academy of Sciences of the United States of America·K Sony ReddyDeepak Gaur
Jan 30, 2015·The New England Journal of Medicine·Katie EwerAdrian V S Hill

❮ Previous
Next ❯

Citations

Jan 3, 2019·Expert Review of Vaccines·K L WilsonM Plebanski
Feb 13, 2019·FEMS Microbiology Reviews·Amy L BurnsDanny W Wilson
Jul 22, 2019·Proteins·Shira WarszawskiSarel J Fleishman
Apr 28, 2019·Nature Communications·Alexander D DouglasSimon J Draper
Dec 27, 2019·Expert Review of Vaccines·Elena StylianouHelen McShane
Jan 31, 2020·PLoS Neglected Tropical Diseases·Rob Hooft van HuijsduijnenKei Katsuno
Dec 13, 2019·Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·Wolfram Gottfried MetzgerCarsten Köhler
Jun 20, 2019·Frontiers in Immunology·Joseph J IllingworthSimon J Draper
Jun 30, 2018·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·Jose Antonio Garrido-CardenasFrancisco Manzano-Agugliaro
Jan 9, 2019·Frontiers in Immunology·Eduardo L V SilveiraIrene S Soares
Feb 9, 2019·Expert Review of Vaccines·Martha M CooperDenise L Doolan
Feb 7, 2019·Nature Communications·Linda ReilingJames G Beeson
Feb 23, 2020·Journal of Cell Science·Maria Fátima HortaThiago Castro-Gomes
Jun 23, 2020·NPJ Vaccines·Patrick E Duffy, J Patrick Gorres
Sep 12, 2018·Annual Review of Microbiology·Matthew B Laurens
Jan 28, 2021·Expert Review of Vaccines·Danielle I Stanisic, Matthew B B McCall
Feb 14, 2021·NPJ Vaccines·Patrick E Duffy, J Patrick Gorres
Jun 3, 2021·Genes·Mirko Pegoraro, Gareth D Weedall
Jun 12, 2021·Journal of Molecular Biology·Matthew K Higgins
Aug 3, 2021·Frontiers in Immunology·Hans de GraafSumi Biswas
Aug 9, 2021·International Journal of Biological Macromolecules·Arjun Singh RaghuwanshiSanjay Singh
Dec 15, 2020·ACS Biomaterials Science & Engineering·Lampouguin Yenkoidiok-Douti, Christopher M Jewell
Sep 8, 2021·Malaria Journal·Brian GreenwoodDaniel Chandramohan

❮ Previous
Next ❯

Methods Mentioned

BETA
ELISA
glycosylation
peptide
ELISAs

Clinical Trials Mentioned

NCT02181088

Software Mentioned

MalariaGEN
GraphPad
AVEXIS
GraphPad Prism

Related Concepts

Related Feeds

Cell-Type Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Cell-Type-Specific Viral Vectors (ASM)

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Cell-Type-Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.